mikessh opened this issue 6 months ago · 0 comments
Kirk et al. DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma. Cell Rep Med 2024
Need more info on actual peptide<>TCR(?), write to authors